acarix News August 6, 2024 11 Oct 2022 “Vår teknologi kan verkligen förändra sjukvården” Bröstsmärta är en vanlig anledning till att söka vård. Men det är bara 10 procent av de som söker vård som till sist diagnostiseras med... Continue reading
acarix News August 6, 2024 26 Sep 2022 Acarix and the American College of Cardiology announce strategic collaboration The American College of Cardiology (“ACC”) and Acarix have signed a strategic collaboration agreement with the goal to develop a clinic... Continue reading
acarix News August 6, 2024 22 Sep 2022 Helen Ljungdahl Round, President and CEO presents at Redeye event, Theme: Diagnostics On September 27 at 9.00am CEST, Helen Ljungdahl Round, President and CEO at Acarix presented the company´s latest developments within d... Continue reading
acarix News August 6, 2024 06 Sep 2022 Highlights from the European Society of Cardiology Congress 2022 In the Special Session ‘Best of the European Heart Journal – Digital Health’ Simon Winther, MD, PhD, Gødstrup Hospital, Denmark was inv... Continue reading
acarix News August 6, 2024 04 Jul 2022 Samuel Schmidt, Co-founder at Acarix has received the Danish MedTech Society’s Rosenfalck Prize. "At the Annelise Rosenfalck Celebration, I received the Danish MedTech Society’s Rosenfalck Prize for my innovations. Annelise Ros... Continue reading
acarix News August 6, 2024 21 Jun 2022 Svensk AI-teknik förbättrar utredning av bröstsmärtor i USA Publicerad i Dagens industri, 21 juni 2022I över 15 år har det svenska medicintekniska företaget Acarix utvecklat den AI-baserade tekno... Continue reading
acarix News August 6, 2024 12 May 2022 Acarix at Naventus Health Care Summit 2022 Helen Ljungdahl Round, President and CEO of Acarix AB (publ), presented at the Naventus Health Care Summit in Stockholm on May 10, 2022... Continue reading
acarix News August 6, 2024 03 Mar 2022 CADScor®System recognized as Most Innovative Coronary Artery Disease Analytical Device 2021. Acarix and CADScor®System has won the Global Health & Pharma technology awards 2021 as Most Innovative Coronary Artery Disease Anal... Continue reading